#InnovativeMedicine

A groundbreaking study published in Nature reveals that psychedelics such as psilocybin may do far more than alter perception or mood—they fundamentally rewire the communication between the brain and the immune system, potentially revolutionizing the treatment of psychiatric and inflammatory conditions worldwide. This research, led by a Harvard Medical School assistant professor and conducted at Brigham and Women’s Hospital, suggests a paradigm shift for mental health therapies, moving beyond neurotransmitter-focused interventions to include neuroimmune pathways as central targets for future drugs and treatments (Neuroscience News; Nature).